Section Arrow
Quote
IMDX.NASDAQ
- Insight Molecular Diagnostics Inc
Quotes are at least 15-min delayed:2026/05/14 06:49 EDT
Pre Market
Last
 4.96
-0.14 (-2.75%)
Bid
4.9
Ask
5.37
High 4.96 
Low 4.94 
Volume 50 
Regular Hours (Closed)
Last
 5.1
+0.12 (+2.41%)
Day High 
5.39 
Prev. Close
4.98 
1-M High
5.35 
Volume 
288.46K 
Bid
4.9
Ask
5.37
Day Low
4.93 
Open
4.99 
1-M Low
2.7 
Market Cap 
160.79M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.67 
20-SMA 4.21 
50-SMA 4.18 
52-W High 8.51 
52-W Low 2.33 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.65/-0.31
Enterprise Value
162.48M
Balance Sheet
Book Value Per Share
-0.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.06M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QUCYQuantum Cyber NV1.34+1.0172+315.12%-- 
Pre Market 1.6404 +0.3004 +22.42%
SHCSotera Health Company15.48-0.15-0.96%37.76PE
Pre Market 14.51 -0.97 -6.27%
DHRDanaher Corp165.99-0.27-0.16%32.17PE
Pre Market 166.78 +0.79 +0.48%
PSNLPersonalis6.39+0.35+5.79%-- 
Pre Market 6.59 +0.2 +3.13%
QGENQiagen NV32.7-1-2.97%16.67PE
Pre Market 33.26 +0.56 +1.71%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.